Dr. Devika G. Das
Claim this profileVeterans Administration Medical Center - Birmingham
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
13 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR negative
ALK negative
2Non-Small Cell Lung Cancer
Stage IV
MET positive
PD-L1 positive
Affiliated Hospitals
Clinical Trials Devika G. Das is currently running
Iadademstat + Atezolizumab/Durvalumab
for Small Cell Lung Cancer
This phase I/II trial tests the safety, side effects, and best dose of iadademstat when given together with atezolizumab or durvalumab, and studies the effect of the combination in treating patients with small cell lung cancer that has spread outside of the lung in which it began or to other parts of the body (extensive stage) who initially received standard of care chemotherapy and immunotherapy. Iadademstat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as atezolizumab or durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding iadademstat to either atezolizumab or durvalumab may be able to stabilize cancer for longer than atezolizumab or durvalumab alone in treating patients with extensive stage small cell lung cancer.
Recruiting1 award Phase 1 & 25 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
More about Devika G. Das
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Devika G. Das has experience with
- Cabozantinib S-malate
- Nab-paclitaxel
- Nivolumab
- Biospecimen Collection
- Data Collection
- Quality-of-Life Assessment
Breakdown of trials Devika G. Das has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Devika G. Das specialize in?
Devika G. Das focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR negative.
Is Devika G. Das currently recruiting for clinical trials?
Yes, Devika G. Das is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Devika G. Das has studied deeply?
Yes, Devika G. Das has studied treatments such as Cabozantinib S-malate, Nab-paclitaxel, Nivolumab.
What is the best way to schedule an appointment with Devika G. Das?
Apply for one of the trials that Devika G. Das is conducting.
What is the office address of Devika G. Das?
The office of Devika G. Das is located at: Veterans Administration Medical Center - Birmingham, Birmingham, Alabama 35233 United States. This is the address for their practice at the Veterans Administration Medical Center - Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.